This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany

Welcome to BIO-Europe Press Center

Your comprehensive resource for the latest news, announcements, and media information from BIO-Europe. Access official press releases, apply for press accreditation, and stay informed about the epicenter of biotech.

Press Release

Official BIO-Europe 2026 press center

BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum

2026 marks BIO-Europe's evolution from partnering-led conference into the continent's largest biopharma strategy forum

BIO-Europe® Innovation Statement

At BIO-Europe® in Vienna, biotechnology associations from Europe, Asia, and North America issued the event's first Innovation Statement—a unified call to action focused on harmonising, defragmenting, accelerating, and scaling biotechnology ecosystems worldwide. This landmark statement positions biotech as a strategic imperative for global economic and technological advancement, reflecting collaboration across regions of varying maturity as geopolitical shifts intensify the sector's importance.

Press Pass: Your Access to Industry-Defining Conversations

Cover the epicenter of biotech – in Europe, for the world. BIO-Europe 2026 (9-11 November, Cologne) is where the biopharma C-suite meets to forge partnerships, shape strategy, and set the global industry agenda.

Press passes provide access to:

  • Seven integrated conference tracks covering regulatory, clinical, manufacturing strategy, and dealmaking
  • High-impact plenary sessions addressing forces reshaping the biopharma industry
  • Networking opportunities with C-suite executives from biotech, pharma, and investment sectors
  • Press conference facilities and media resources

Eligibility: Accredited journalists, editors, and media representatives from recognised publications covering life sciences, biotechnology, and healthcare sectors.